Atlas Trials

Hyper-Personalized Medicine Using Patient Derived Xenografts (PDXovo) for Metastatic Solid Tumors

Clinical trial NCT04602702 · UNKNOWN

Trial details

NCT number
NCT04602702
Sponsor
Sunnybrook Health Sciences Centre
Status
UNKNOWN
Study type
OBSERVATIONAL
Kidney NeoplasmCarcinoma, Renal CellMetastatic Solid Tumor
Start date
2020-12-01
Primary completion
2022-12-31
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.